Subsequently, functional investigations demonstrated that SLC2A11–MIF enhanced the proliferation, antiapoptotic effects, and metastasis of bladder cancer cells in vitro and in vivo. This evidence concerns the gene SLC2A11 and urinary bladder carcinoma.